Pharma Stock in Motilal Oswal’s Portfolio Achieves 155% Profit CAGR Over Three Years
A US-focused pharmaceutical company has reported impressive growth, with profits more than doubling year-on-year, supported by a strong CAGR and strategic acquisitions.
Editorial Staff 2 days ago